Beyond Air
Pre-clinicalBeyond Air is a clinical-stage medical device and biopharmaceutical company using nitric oxide to treat respiratory and other diseases.
Founded
2015
Focus
RespiratoryInfectious Disease
About
Beyond Air is a clinical-stage medical device and biopharmaceutical company using nitric oxide to treat respiratory and other diseases.
Funding History
4Total raised: $135M
IPO$75MUndisclosedFeb 11, 2021
Series C$30MPerceptive AdvisorsJan 15, 2020
Series B$20MMedytoxMar 15, 2018
Series A$10MPontifaxJun 15, 2016
Company Info
TypePrivate
Founded2015
LocationGarden City, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile